Phototherapy For Treatment Of Raynaud's Phenomenon

Status Withdrawn

Clinical Trial Summary

To determine if blue light therapy can improve the symptoms of Raynaud's phenomenon, and provide parameters for ultimately designing commercial treatment devices, an investigational stationary phototherapy unit was designed and built.

Clinical Trial Description

The purpose of this study is to test the efficacy of blue light phototherapy for the treatment of Raynaud's phenomenon (RP) in human participants. The specific aim is to see if phototherapy treatment applied to the hands will reduce the symptoms that RP participants experience. This will be measured through the use of a visual analog scale (VAS) of both pain and numbness. This study will also help to infer whether blue light phototherapy causes vasodilation through infrared thermal imaging of the hands and continuous measurement of skin temperature with a surface thermistor. Together, the visual analog scale (VAS) and infrared thermal imaging contribute to the objective of deducing whether blue light phototherapy can lead to reduced RP symptoms due to vasodilation of blood vessels. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04898036
Study type	Interventional
Source	University of Minnesota
Contact
Status	Withdrawn
Phase	N/A
Start date	August 2022
Completion date	March 2023

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03393325` - Tadalafil-Delivra and Raynaud's Phenomenon
Recruiting	`NCT03749577` - Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon	N/A
Completed	`NCT03699436` - Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon	N/A
Enrolling by invitation	`NCT06291142` - Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
Recruiting	`NCT03984422` - Application for Monitoring and Evaluation of Raynaud's Phenomenon
Recruiting	`NCT04015193` - Follow-up of SPTS in Patients With Raynaud's Phenomenon
Not yet recruiting	`NCT03972566` - Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon
Completed	`NCT04854850` - Apollo Device for Fatigue in Systemic Sclerosis	N/A
Completed	`NCT03129178` - Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon	N/A
Completed	`NCT04388176` - Cold Challenge With C21 in RP	Phase 2
Completed	`NCT01280266` - Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon	Phase 2/Phase 3
Completed	`NCT04644523` - Dermoscopy in Primary Raynaud's Phenomenon
Completed	`NCT03094910` - Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon	N/A
Recruiting	`NCT05204784` - Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis	N/A
Recruiting	`NCT05125029` - Botulinum Toxin in Raynaud's Phenomenon	Phase 4
Terminated	`NCT03639766` - The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon	Phase 4
Terminated	`NCT03869008` - Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.	N/A
Recruiting	`NCT01347008` - Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis	Phase 3